Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Closed: Mar 19, 06:07 AM 2010 
  NYSE  7443.57    NASDAQ  2391.28   		Search is sponsered by    
  



Processing
Collecting necessary data for BVF...

Biovail Corporation financials, fundamentals and performance

    
15.80
Intraday
 
One Month
 0.00   No Change   0.00%  
    
 BVF Biovail Corporation
 Trade It Now
 
    
Macroaxis: United States NYSE
    
Market Cap 2.502B   Book Value 8.555   EBITDA 361.3M   Year Low 9.26   Year High 16.14   PEG Ratio 6.50   EPS 1.113   P/E 14.20   P/B Ratio 1.85   Short Ratio 4.40   Sector Healthcare   Full Time Employees 1,291   Industry Drug Delivery   Last Close 15.80   Target Price 16.51   Current EPS 1.113   This Year EPS 0.98   Next Year EPS 1.29   Current PE 14.20   This Year PE 16.12   Next Year PE 12.25   Dividend 0.36   Dividend Yield 2.28   Dividend Date Apr  5  

30-Days Risk-Return Take

    
BiovailRisk FreeMarket
    

Profile

    
Suggest       

Today

  
Biovail Corporation, a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products used in the treatment of specialty central nervous system disorders.
 Macroaxis: thisGreen BVF   0.00 % No Change  
 
 Macroaxis: United States NYA   0.00 % No Change  
 
 Macroaxis: United States GSPC   0.00 % No Change  
 
 Macroaxis: United States IXIC   0.00 % No Change  
 
    
    
    

Performance    Embed Financials

    
    
 Embed Financials
 Compare Biovail To   
    
Hospira  Elan  Nektar  Alkermes  PetMed  Acura  Delcath  Flamel  Penwest  pSivida  Matrixx 
 Risk & Return  Correlation
    

30-Days Moving Rating

    

Macroaxis Total Score 

    
7
Embed Financials
Current 30 Days Moving Rating
HospiraBiovailMatrixxFlamelPenwest
    
BVF financials 

Current Net Investing Interest   

 
 5 
    

Estimated Market Risk

 1.34
  actual daily
 
 82 %
of total potential
 
Market Risk score

Expected Return

 0.26
  actual daily
 
 10 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 0.19
  actual daily
 
 10 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average   [ change ] 
Increase Risk-Adjusted return of BVF by adding it to a well-diversified portfolio
Diversify